ImmuCell Corporation
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +32.1% | +69.2% | +38.9% | -4.6% | +18.2% | +4.3% | +10.2% | +0.9% | -2.3% | +3.0% | -5.7% | |
| – | +44.0% | +82.2% | -47.7% | -14.5% | +105.4% | -7.8% | +33.8% | -14.0% | -18.0% | +31.2% | +12.6% | |
| – | +85.1% | +227.4% | -26.2% | -33.6% | +149.6% | +26.3% | +28.2% | -43.1% | -83.1% | +284.0% | +1.3% | |
| – | +80.8% | +76.0% | -64.2% | -33.6% | +248.0% | -9.4% | +28.2% | -43.1% | -83.1% | +284.0% | +1.3% | |
| – | -25.0% | +50.8% | +31.3% | -4.6% | +17.7% | +11.1% | +45.9% | -33.8% | +21.4% | +74.4% | -10.3% | |
| – | -8.0% | +144.4% | -3.6% | +13.8% | +8.0% | -16.9% | +47.7% | +95.4% | +29.4% | -9.0% | +30.3% | |
| – | +49.0% | +72.2% | +164.8% | -0.2% | -2.9% | +10.7% | +0.1% | +109,305.0% | – | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | -11.1% | -12.5% | -14.3% | -16.7% | -20.0% | -25.0% | -33.3% | -50.0% | – | |
| – | +122.3% | +24.8% | +115.2% | +2.6% | -11.7% | +24.6% | -1.6% | +21.8% | +29.9% | -6.6% | -12.0% | |
| – | -18.9% | +151.8% | +0.2% | +24.3% | -2.7% | -11.4% | +14.6% | +21.2% | +36.6% | +5.1% | -9.8% | |
| – | -9.7% | -1.9% | +137.6% | +324.6% | -5.2% | -32.5% | +6.9% | +16.4% | +93.5% | -6.9% | -12.1% | |
| – | -56.0% | +651.3% | -18.9% | -50.6% | -5.2% | +5.3% | +23.7% | +6.0% | +12.4% | +6.3% | -15.6% | |
| – | +303.9% | -8.0% | +196.3% | -2.5% | -15.1% | +22.3% | -4.7% | +10.4% | +14.7% | -14.2% | -17.2% | |
| – | +14.6% | +85.8% | +19.6% | -7.8% | +33.3% | -2.5% | +15.3% | -6.7% | -17.7% | +10.1% | -1.7% | |
| – | – | +79.6% | -14.7% | -237.2% | – | – | – | – | – | – | – | |
| – | +4.6% | +37.0% | +14.1% | +10.9% | +24.3% | +5.8% | +5.3% | +2.0% | +0.0% | +5.4% | +10.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.